Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3262)
All Articles published online
|
Oct 14, 2010 (publication date) through May 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ichino N, Osakabe K, Nishikawa T, Sugiyama H, Kato M, Kitahara S, Hashimoto S, Kawabe N, Harata M, Nitta Y, Murao M, Nakano T, Arima Y, Shimazaki H, Suzuki K, Yoshioka K. A new index for non-invasive assessment of liver fibrosis. World J Gastroenterol 2010; 16(38): 4809-4816 [PMID: 20939109 DOI: 10.3748/wjg.v16.i38.4809] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i38/4809.htm |
| Number | Citing Articles |
| 1 |
Masaya Saito, Yoshihiko Yano, Hirotaka Hirano, Kenji Momose, Masaru Yoshida, Takeshi Azuma. Serum NX-DCP as a New Noninvasive Model to Predict Significant Liver Fibrosis in Chronic Hepatitis C. Hepatitis Monthly 2015; 15(2) doi: 10.5812/hepatmon.22978
|
| 2 |
Cristina Stasi, Stefano Milani. Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness. World Journal of Gastroenterology 2016; 22(4): 1711-1720 doi: 10.3748/wjg.v22.i4.1711
|
| 3 |
Keisuke Osakabe, Naohiro Ichino, Toru Nishikawa, Hiroko Sugiyama, Miho Kato, Shiho Kitahara, Senju Hashimoto, Naoto Kawabe, Masao Harata, Yoshifumi Nitta, Michihito Murao, Takuji Nakano, Hiroaki Shimazaki, Yuko Arima, Koji Suzuki, Kentaro Yoshioka. Reduction of liver stiffness by antiviral therapy in chronic hepatitis B. Journal of Gastroenterology 2011; 46(11): 1324 doi: 10.1007/s00535-011-0444-4
|
| 4 |
Manuela G. Neuman, Lawrence B. Cohen, Radu M. Nanau. Hyaluronic acid as a non-invasive biomarker of liver fibrosis. Clinical Biochemistry 2016; 49(3): 302 doi: 10.1016/j.clinbiochem.2015.07.019
|
| 5 |
Su-Mei Li, Guang-Xia Li, Dong-Mei Fu, Yu Wang, Li-Qun Dang. Liver fibrosis evaluation by ARFI and APRI in chronic hepatitis C. World Journal of Gastroenterology 2014; 20(28): 9528-9533 doi: 10.3748/wjg.v20.i28.9528
|
| 6 |
P. Calès, J. Boursier, J. Lebigot, V. de Ledinghen, C. Aubé, I. Hubert, F. Oberti. Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination?. Alimentary Pharmacology & Therapeutics 2017; 45(7): 991 doi: 10.1111/apt.13954
|
| 7 |
Alexandra Ducancelle, Vincent Leroy, Julien Vergniol, Nathalie Sturm, Brigitte Le Bail, Jean Pierre Zarski, Eric Nguyen Khac, Dominique Salmon, Victor de Ledinghen, Paul Calès. A Single Test Combining Blood Markers and Elastography is More Accurate Than Other Fibrosis Tests in the Main Causes of Chronic Liver Diseases. Journal of Clinical Gastroenterology 2017; 51(7): 639 doi: 10.1097/MCG.0000000000000788
|
| 8 |
Yuan Zhang, Ying Zheng, Xuesong Yang, Xuqing Liu, Haiying Zhang, Xiaoluan Xu, Fankun Meng. Comparison of Acoustic Structure Quantification, Transient Elastography (FibroScan) and Histology in Patients with Chronic Hepatitis B and without Moderate to Severe Hepatic Steatosis. Ultrasound in Medicine & Biology 2019; 45(3): 684 doi: 10.1016/j.ultrasmedbio.2018.10.007
|
| 9 |
Mohamed Said, Zeinab Soliman, Hosam Daebes, Saeed M El-Nahaas, Magdy El-Serafy. Real life application of FIB-4 & APRI during mass treatment of HCV genotype 4 with directly acting anti-viral agents in Egyptian patients, an observational study. Expert Review of Gastroenterology & Hepatology 2019; 13(12): 1189 doi: 10.1080/17474124.2019.1690990
|
| 10 |
Xing-Xi Gao, Da-Hua Shi, Yun-Xi Chen, Jiang-Tao Cui, Yu-Rong Wang, Chun-Ping Jiang, Jun-Hua Wu. The therapeutic effects of tectorigenin on chemically induced liver fibrosis in rats and an associated metabonomic investigation. Archives of Pharmacal Research 2012; 35(8): 1479 doi: 10.1007/s12272-012-0819-y
|
| 11 |
B Liang, Y Li, A Zhao, F Xie, Z Guo. Clinical Utility of Serum Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-2 Concentrations in the Assessment of Liver Fibrosis due to Chronic Hepatitis B. Journal of International Medical Research 2012; 40(2): 631 doi: 10.1177/147323001204000225
|
| 12 |
Shelley S Selph, Alexander D Ginsburg, Roger Chou. Impact of contacting study authors to obtain additional data for systematic reviews: diagnostic accuracy studies for hepatic fibrosis. Systematic Reviews 2014; 3(1) doi: 10.1186/2046-4053-3-107
|
| 13 |
Kentaro Yoshioka, Senju Hashimoto. Can non‐invasive assessment of liver fibrosis replace liver biopsy?. Hepatology Research 2012; 42(3): 233 doi: 10.1111/j.1872-034X.2011.00928.x
|
| 14 |
Rafael Torres-Valadez, Sonia Roman, Alexis Jose-Abrego, Maricruz Sepulveda-Villegas, Claudia Ojeda-Granados, Ingrid Rivera-Iñiguez, Arturo Panduro. Early detection of liver damage in Mexican patients with chronic liver disease. Journal of Translational Internal Medicine 2017; 5(1): 49 doi: 10.1515/jtim-2017-0003
|
| 15 |
Prediction of Hepatocellular Carcinoma Incidence Risk by Ultrasound Elastography. Liver Cancer 2014; 3(1): 1 doi: 10.1159/000343859
|